Clinical Trials Directory

Trials / Terminated

TerminatedNCT01790113

Arthrex Eclipse™ Shoulder Prosthesis

A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
303 (actual)
Sponsor
Arthrex, Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

A Prospective, Randomized, Multicenter Study comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder to the Univers™ II Shoulder Prosthesis in patients with a degenerative joint disease.

Detailed description

The purpose of this study is to demonstrate non-inferiority of the Arthrex Eclipse™ Shoulder Prosthesis to the Arthrex Univers™ II Shoulder Prosthesis for the treatment of degenerative joint disease in subjects who are candidates for total shoulder replacement. Non-inferiority in terms of safety and effectiveness will be measured by a 2 year composite clinical success (CCS) that requires functional improvement, radiographic success, absence of reoperations and revision, and lack of serious device-related adverse events.

Conditions

Interventions

TypeNameDescription
DEVICEUnivers™Control
DEVICEEclipse™ Total Shoulder ReplacementInvestigational

Timeline

Start date
2013-02-04
Primary completion
2019-06-07
Completion
2019-06-07
First posted
2013-02-13
Last updated
2021-02-03
Results posted
2021-01-29

Locations

16 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01790113. Inclusion in this directory is not an endorsement.